Medicover Financial Statements From 2010 to 2026
| MCVEF Stock | USD 27.25 0.00 0.00% |
Check Medicover financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medicover's main balance sheet or income statement drivers, such as , as well as many indicators such as . Medicover financial statements analysis is a perfect complement when working with Medicover Valuation or Volatility modules.
Medicover |
Medicover AB Company Return On Asset Analysis
Medicover's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Medicover Return On Asset | 0.0401 |
Most of Medicover's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medicover AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Medicover AB has a Return On Asset of 0.0401. This is 100.46% lower than that of the Healthcare sector and significantly higher than that of the Medical Care Facilities industry. The return on asset for all United States stocks is 128.64% lower than that of the firm.
Medicover AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Medicover's current stock value. Our valuation model uses many indicators to compare Medicover value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medicover competition to find correlations between indicators driving Medicover's intrinsic value. More Info.Medicover AB is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about 0.52 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Medicover AB is roughly 1.91 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medicover's earnings, one of the primary drivers of an investment's value.About Medicover Financial Statements
Medicover stakeholders use historical fundamental indicators, such as Medicover's revenue or net income, to determine how well the company is positioned to perform in the future. Although Medicover investors may analyze each financial statement separately, they are all interrelated. For example, changes in Medicover's assets and liabilities are reflected in the revenues and expenses on Medicover's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Medicover AB. Please read more on our technical analysis and fundamental analysis pages.
Medicover AB provides healthcare and diagnostic services in Germany, Sweden, Poland, Turkey, Belarus, Bulgaria, Georgia, Hungary, Serbia, Moldova, Ukraine, and India. Medicover AB was founded in 1995 and is headquartered in Stockholm, Sweden. Medicover is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Medicover Pink Sheet
Medicover financial ratios help investors to determine whether Medicover Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medicover with respect to the benefits of owning Medicover security.